Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand
© 2020 The Authors A new generation of recombinant acellular pertussis vaccine containing genetically inactivated pertussis toxin (PTgen) was licensed as a monovalent pertussis vaccine (aPgen; Pertagen®) and in combination with tetanus and reduced-dose diphtheria (TdaPgen; Boostagen®) for active imm...
Saved in:
Main Authors: | Librada Fortuna, Surasith Chaithongwongwatthana, Ngamphol Soonthornworasiri, Jane Spiegel, Wassana Wijagkanalan, Souad Mansouri, Anita H.J. van den Biggelaar, Hong Thai Pham |
---|---|
Other Authors: | Chulalongkorn University |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/59894 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP<inf>gen</inf> or combined TdaP<inf>gen</inf> vaccines
by: Punnee Pitisuttithum, et al.
Published: (2022) -
Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial
by: Punnee Pitisuttithum, et al.
Published: (2019) -
Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women
by: Nalat Sompagdee, et al.
Published: (2020) -
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial
by: Geraldine Blanchard Rohner, et al.
Published: (2020) -
Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants
by: Shek, L.P.C., et al.
Published: (2013)